T-cell receptor (TCR) (TCR)

The T-cell receptor (TCR) is a multi-subunit protein complex found on the surface of T cells that is responsible for recognizing fragments of antigen as peptides bound to major histocompatibility complex (MHC) molecules. This interaction is the fundamental event in the adaptive immune response, triggering T cell activation, proliferation, and effector functions such as the killing of virally infected or cancerous cells. The TCR complex typically consists of an antigen-binding heterodimer (alpha/beta or gamma/delta chains) non-covalently associated with CD3 signaling subunits. In modern oncology, the TCR is a primary focus for therapeutic intervention, including the development of TCR-engineered T-cell (TCR-T) therapies and bispecific T-cell engagers (BiTEs) that bypass or enhance natural antigen recognition. Challenges in targeting the TCR include the requirement for specific HLA matching in pMHC-directed therapies and the risk of severe systemic inflammatory responses like cytokine release syndrome. Pharmacological modulation of the TCR pathway is also critical in managing autoimmune diseases and preventing transplant rejection. The specificity of the TCR for a particular peptide-MHC complex allows for highly targeted immunotherapy, though it necessitates precise patient selection based on HLA typing.

Other names

T-cell receptor complexTCR-CD3 complexAntigen-specific T-cell receptorMHC-restricted T-cell receptor

Direct binding and activation of the TCR/CD3 complex, redirection of T-cell cytotoxicity via bispecific engagement, and adoptive transfer of T cells expressing engineered antigen-specific TCRs.